Global Biopsy Devices Market US$ 2.2 billion by 2021

The global biopsy devices market expected to reach US$ 2.2 billion by 2021, growing at CAGR 5.8% over the forecast period 2017-2021, owing to increased rates of cancer, higher preference for minimal invasive technologies and rising geriatric population worldwide.

Browse Biopsy Devices Market by Product Types (Needle-Based Guns -Vacuum-Assisted, Core Needle, Fine Needle Aspiration; Biopsy Needles – Disposable, Reusable; Biopsy Forceps – Cold and Hot; Guidance Systems – Manual and Robotic) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/biopsy-devices-market/

The global biopsy devices market report provides market size estimates (Revenue USD million - 2014 to 2021) for key market segments based on product type (needle-based guns -vacuum-assisted, core needle, fine needle aspiration; biopsy needles – disposable, reusable; biopsy forceps – cold and hot; guidance systems – manual and robotic), and forecasts growth trends (CAGR% - 2017 to 2021). The global biopsy devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global biopsy devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global biopsy devices market and included in this report are Angiotech, C R Bard Inc., CareFusion Corporation, Devicor Medical Products Inc. and Hologic Inc.

1. Device Type
1.1. Needle-based Biopsy Guns
1.1.1. Vacuum-assisted Biopsy (VA) Devices
1.1.2. Core Needle Biopsy (CN) Devices
1.1.3. Fine Needle Aspiration Biopsy (FNA) Devices
1.2. Biopsy Needles
1.2.1. Disposable
1.2.2. Reusable
1.3. Biopsy Forceps
1.3.1. Cold (General) Biopsy Forceps
1.3.2. Hot Biopsy Forceps
1.4. Biopsy Guidance Systems
1.4.1. Manual Systems
1.4.2. Robotic Systems
1.5. Others (Brushes, Curettes, Punches)

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Angiotech
3.2. C. R. Bard, Inc.
3.3. Cardinal Health Inc.
3.4. Carefusion Corporation
3.5. Devicor Medical Products, Inc.
3.6. DTR Medical
3.7. Hologic, Inc.
3.8. INRAD, Inc.
3.9. UK Biopsy

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/biopsy-devices-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.